Fused bicyclic pyrimidine derivatives and uses thereof

作者: Nathanael S. Gray , Tinghu Zhang

DOI:

关键词: NeuroblastomaChemistryCDK12ProdrugCancer researchSarcomaCyclin-dependent kinase 7KinaseMelanomaCyclin-dependent kinase

摘要: The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, compositions thereof. Also provided are methods kits involving the inventive or for treating preventing proliferative diseases (e.g., cancers lung cancer, breast leukemia, lymphoma, melanoma, multiple myeloma, Ewing's sarcoma, osteosarcoma, brain neuroblastoma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory autoimmune diseases) in a subject. Treatment subject with disease using compound composition may inhibit aberrant activity kinase (e.g. protein cyclin-dependent (CDK) CDK7, CDK12, CDK13) lipid such as phosphatidylinositol- 5 -phosphate 4- (PIP4K) ΡΙ5Ρ4Κα, ΡΙ5Ρ4Κβ, ΡΙ5Ρ4Κγ))

参考文章(13)
Mélissanne de Wispelaere, Nathanael S. Gray, Priscilla L. Yang, Qingsong Liu, Host targeted inhibitors of dengue virus and other viruses ,(2013)
Lucia E. Rameh, Kimberley F. Tolias, Brian C. Duckworth, Lewis C. Cantley, A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate Nature. ,vol. 390, pp. 192- 196 ,(1997) , 10.1038/36621
Nathanael S. Gray, Li Tan, Janus kinase inhibitors and uses thereof ,(2015)
Pixu Liu, Hailing Cheng, Thomas M. Roberts, Jean J. Zhao, Targeting the phosphoinositide 3-kinase pathway in cancer Nature Reviews Drug Discovery. ,vol. 8, pp. 627- 644 ,(2009) , 10.1038/NRD2926
Brooke M. Emerling, Jonathan B. Hurov, George Poulogiannis, Kazumi S. Tsukazawa, Rayman Choo-Wing, Gerburg M. Wulf, Eric L. Bell, Hye-Seok Shim, Katja A. Lamia, Lucia E. Rameh, Gary Bellinger, Atsuo T. Sasaki, John M. Asara, Xin Yuan, Andrea Bullock, Gina M. DeNicola, Jiaxi Song, Victoria Brown, Sabina Signoretti, Lewis C. Cantley, Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors. Cell. ,vol. 155, pp. 844- 857 ,(2013) , 10.1016/J.CELL.2013.09.057
P. De Camilli, S. D. Emr, P. S. McPherson, P. Novick, Phosphoinositides as Regulators in Membrane Traffic Science. ,vol. 271, pp. 1533- 1539 ,(1996) , 10.1126/SCIENCE.271.5255.1533
Stephane Ciblat, Jason J. Marineau, Nathanael Gray, Tinghu Zhang, Michael Bradley, Anzhelika Kabro, Melissa Leblanc, Darby Schmidt, Tom Miller, Dana K. Winter, Kevin Sprott, M. Arshad Siddiqui, Joel Moore, Stephanie Roy, Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7) ,(2014)
Nathanael S. Gray, Type ii raf kinase inhibitors ,(2010)
Stephane Ciblat, Jason J. Marineau, Nathanael Gray, Tinghu Zhang, Michael Bradley, Serge Leger, Anzhelika Kabro, Patrick Deroy, Melissa Leblanc, Darby Schmidt, Tom Miller, Dana K. Winter, Kevin Sprott, Joel Moore, M. Arshad Sidiqui, Stephanie Roy, Heteroaromatic compounds useful for the treatment of prolferative diseases ,(2014)